The News

Pernod Ricard has posted its first quarter of positive sales growth in several periods, signalling that the worst of the spirits downturn may be passing. The Paris-headquartered group, which controls a significant stable of whisky brands including The Glenlivet, Aberlour, Royal Salute, and Jameson, reported modest underlying revenue gains in its most recent trading update, even as macroeconomic headwinds and tariff uncertainty continued to weigh on global spirits demand. For the whisky trade specifically, the results offer a cautious but concrete data point: destocking cycles appear to be easing, and pull-through at retail and travel retail is firming up after more than a year of subdued ordering patterns.

The group's management pointed to improving momentum across several key markets, though stopped short of declaring a full recovery. Pernod Ricard's Q3 figures for the 2025/26 financial year showed organic growth returning after consecutive quarters of decline, driven in part by stabilisation in the US market and continued resilience in India, where the company's premium whisky portfolio has been a standout performer. Europe remained more mixed, with consumers still trading down in certain categories, but Scotch whisky held relatively firm compared to softer spirits segments such as vodka and gin.

Trade Context

Pernod Ricard's whisky division is one of the largest in the world, and its performance acts as a bellwether for the broader Scotch and Irish whiskey sectors. The Glenlivet, the group's flagship single malt, competes directly with Diageo's Glenfiddich and LVMH's Glenmorangie for global single malt market share, particularly in the United States and Asia-Pacific. Aberlour has been gaining ground in France and duty-free channels, while Royal Salute continues to command premium pricing in South Korea and Greater China. On the Irish side, Jameson remains the world's best-selling Irish whiskey by volume, giving Pernod Ricard significant leverage across both the malt and blended categories.

  • Producer / Distillery: Pernod Ricard (The Glenlivet, Aberlour, Royal Salute, Jameson, Redbreast, Powers)
  • Category: Scotch Single Malt / Blended Scotch / Irish Whiskey
  • Market implication: Easing destocking and returning growth suggest the spirits correction is bottoming out, with potential knock-on effects for cask pricing and new-make demand

The broader context matters here. The spirits industry has endured a bruising eighteen months, characterised by aggressive inventory corrections across the supply chain. Distributors and retailers in the US — the world's largest spirits market by value — had over-ordered during the post-pandemic boom and spent much of 2024 and early 2025 burning through excess stock rather than placing fresh orders. This destocking effect hammered top-line growth for every major spirits company, from Diageo to Brown-Forman, and fed through into weaker demand for bulk Scotch and new-make spirit. Pernod Ricard's return to growth suggests this cycle is now largely complete, at least in the company's key channels.

There is also a tariff dimension. The reintroduction and escalation of US tariffs on European spirits imports has created fresh uncertainty for Scotch whisky producers throughout 2025 and into 2026. Pernod Ricard acknowledged the risk in its trading update but noted that pricing actions and shifting channel mix had partially offset the impact. The group has historically been adept at managing tariff exposure through bonded inventory positioning and supply chain adjustments, a capability that smaller independent bottlers and single-distillery operators may struggle to replicate.

Why It Matters

For the whisky trade, Pernod Ricard's numbers carry weight beyond the corporate earnings cycle. When the majors start reporting volume recovery, it typically foreshadows renewed demand for bulk spirit and cask fills from independent bottlers and brokers who rely on the same underlying production base. If destocking is genuinely behind us, expect new-make spirit prices to stabilise or edge higher through the second half of 2026, particularly for sought-after Speyside and Islay fills. Cask investors holding maturing stock should view this as a broadly positive signal for medium-term exit values.

The recovery also has implications for capital expenditure decisions at distillery level. During the downturn, several producers quietly scaled back production schedules and deferred warehouse expansion plans. A sustained return to growth would justify reopening those investment taps, potentially accelerating capacity builds that had been put on hold. For auction houses and secondary market participants, improving consumer confidence at the premium end of the market tends to support pricing for limited releases and aged stock, though the effect typically lags the corporate recovery by two to three quarters. The smart read here is cautious optimism — the data is pointing in the right direction, but the trade should watch the next quarter closely before assuming the storm has fully passed.